International Business News - ALXA http://www.ibtimes.com All articles are copyrighted by IBTimes.com 400 100 http://www.ibtimes.com/ http://www.ibtimes.com/images/top_logo_ibt2_3.gif Alexza Pharmaceuticals said Tuesday its experimental drug significantly reduced symptoms of schizophrenia in a late-stage trial. The company reported that a study of 344 schizophrenic patients showed AZ-004 significantly reduced agitation compared to placebo. Both a 5 and 10 milligram dose of the drug showed statistically significant results within two hours of treatment. http://www.ibtimes.com/articles/20080902/alexza-reports-good-results-in-schizophrenia-study.htm Tue, 02 Sep 2008 19:40:56 EDT Among the earnings stories for Monday, May 12, from AP Financial News: McLEAN, Va. (AP) _ BearingPoint Inc., a management and technology consultant, said Monday its first-quarter loss shrunk more than 60 percent thanks to sharply lower costs. http://www.ibtimes.com/articles/20080512/earnings-roundup-bearingpoint-energy-transfer-partners.htm Mon, 12 May 2008 18:48:26 EDT Drug developer Alexza Pharmaceuticals Inc. said Monday that its first-quarter loss widened on increased research and development spending. The company lost $14.6 million, or 47 cents per share, compared with $10.9 million, or 46 cents per share, in the year-ago period. http://www.ibtimes.com/articles/20080512/alexza-1q-loss-widens-on-increased-development-costs.htm Mon, 12 May 2008 17:23:06 EDT Among the stock activity stories for Tuesday, March 18, from AP Financial News: NEW YORK (AP) _ Shares of biotechnology company Genzyme Corp. are rising after the company reaffirmed its outlook for long-term growth. http://www.ibtimes.com/articles/20080318/movers-roundup-genzyme-sunpower.htm Tue, 18 Mar 2008 18:26:15 EDT Alexza Pharmaceuticals Inc. shares fell, and reached an all-time low amid concerns that the company lacks the funds needed to develop its drug candidates. http://www.ibtimes.com/articles/20080318/alexza-pharma-falls-on-funding-concerns.htm Tue, 18 Mar 2008 14:08:28 EDT An RBC Capital Markets analyst said Friday that a deal between Alexza Pharmaceuticals Inc. and Endo Pharmaceuticals Holdings Inc. is "extremely valuable" for Alexza because of Endo's experience and skill in developing pain drugs. http://www.ibtimes.com/articles/20071228/ahead-of-the-bell-alexza.htm Fri, 28 Dec 2007 09:01:17 EST